Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01727609
Other study ID # SIFT01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2013
Est. completion date May 10, 2018

Study information

Verified date July 2018
Source University of Oxford
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Survival of preterm infants has increased greatly over the years, so a major aim now is to improve the long term outlook for these babies and to avoid serious complications. The way babies are fed in early life affects short and long-term health and survival.

Because the bowels of preterm infants have not matured, they cannot digest large volumes of milk feeds straight away. Until the gut matures, nutrition is provided by intravenous drip while the amount of milk given is gradually increased over time. Increasing the amount of milk rapidly may increase the risk of gut complications. Increasing the amount of milk given more slowly means that intravenous nutrition is needed for longer; there is an associated risk of infection proportional to the time the intravenous line is present in the bloodstream of these infants. Despite the importance of milk feeding preterm infants, there have been few studies to inform how best to balance these risks, and what the best way to increase feeds in these infants is - this study sets out to address this missing information.

The study will compare two different speeds of milk feed increase, one 'faster' and one 'slower', both within rates currently used in United Kingdom neonatal units. The study aims to find out if either speed of milk feed increase gives better outcomes for the infants. Investigators will measure a variety of outcomes, such as survival without disability, infection, bowel problems, growth and long-term physical and mental development, as well as the impact on families and the National Health Service, including costs.

The study is being led by an established team of researchers who have run similar studies before, and uses an established network of neonatal units that have taken part in previous studies.


Recruitment information / eligibility

Status Completed
Enrollment 2804
Est. completion date May 10, 2018
Est. primary completion date May 10, 2018
Accepts healthy volunteers No
Gender All
Age group N/A to 32 Weeks
Eligibility Inclusion Criteria:

- Gestational age at birth <32 weeks, or birth weight less than 1,500 g

- Receiving =30 ml/kg/day of milk at randomisation

- Written informed parental consent is obtained

To ensure the widest applicability to preterm infants across the United Kingdom, those exclusively breast milk fed, formula milk fed, or receiving mixed feeds will be included

Exclusion Criteria:

- Infants with a severe congenital anomaly

- Infants who, in the opinion of the treating clinician, have no realistic chance of survival

- Infants who are unlikely to be traceable for follow-up at 24 months of age corrected for prematurity (for example, infants of non-United Kingdom residents)

Study Design


Intervention

Dietary Supplement:
Milk feed (breast milk or formula milk)


Locations

Country Name City State
Ireland National Maternity Hospital, Dublin Dublin
United Kingdom William Harvey Hospital Ashford
United Kingdom Royal Maternity Hospital, Belfast Belfast
United Kingdom Birmingham City Hospital Birmingham
United Kingdom Birmingham Heartlands Hospital Birmingham
United Kingdom Birmingham Women's Hospital Birmingham
United Kingdom Bradford Royal Infirmary Bradford
United Kingdom Southmead Hospital Bristol
United Kingdom St Michael's Hospital Bristol
United Kingdom St Peters Hospital Chertsey
United Kingdom Countess of Chester Hospital Chester
United Kingdom University Hospital Coventry Coventry
United Kingdom Leighton Hospital Crewe
United Kingdom Derbyshire Children's Hospital Derby
United Kingdom Royal Infirmary of Edinburgh Edinburgh
United Kingdom Royal Devon and Exeter Hospital Exeter
United Kingdom Princess Royal Maternity Hospital, Glasgow Glasgow
United Kingdom Southern General Hospital Glasgow
United Kingdom Gloucestershire Royal Hosptial Gloucester
United Kingdom Calderdale Royal Hospital Halifax
United Kingdom Hull Royal Infirmary Hull
United Kingdom Kettering General Hospital Kettering
United Kingdom Leeds General Infirmary Leeds
United Kingdom St James's University Hospital Leeds
United Kingdom Leicester Royal Infirmary Leicester
United Kingdom Lincoln County Hospital Lincoln
United Kingdom St George's Hospital London
United Kingdom Altnagelvin Area Hospital Londonderry
United Kingdom James Cook University Hospital Middlesbrough
United Kingdom Royal Victoria Infirmary Newcastle
United Kingdom Northampton General Hospital Northampton
United Kingdom Nottingham City Hospital Nottingham
United Kingdom Queen's Medical Centre Nottingham
United Kingdom John Radcliffe Hospital Oxford
United Kingdom Derriford Hospital Plymouth
United Kingdom Craigavon Area Hospital Portadown
United Kingdom Queen Alexandra Hospital, Portsmouth Portsmouth
United Kingdom Royal Berkshire Hospital Reading
United Kingdom Queen's Hospital, Romford Romford
United Kingdom Jessop Wing, Sheffield Sheffield
United Kingdom Royal Shrewsbury Hospital Shrewsbury
United Kingdom Princess Anne Hospital, Southampton Southampton
United Kingdom University Hospital of North Tees Stockton on Tees
United Kingdom Royal Stoke University Hospital Stoke-on-Trent
United Kingdom Sunderland Royal Hospital Sunderland
United Kingdom King's Mill Hospital Sutton-in-Ashfield
United Kingdom Singleton Hospital Swansea
United Kingdom Great Western Hospital, Swindon Swindon
United Kingdom Croydon University Hospital Thornton Heath
United Kingdom Royal Cornwall Hospital Truro
United Kingdom Arrowe Park Hospital, Wirral Upton
United Kingdom Pinderfields General Hospital Wakefield
United Kingdom Warrington Hospital Warrington
United Kingdom Wishaw General Hospital Wishaw
United Kingdom New Cross Hospital Wolverhampton
United Kingdom Worcestershire Royal Hospital Worcester
United Kingdom York Hospital York

Sponsors (2)

Lead Sponsor Collaborator
University of Oxford National Institute for Health Research, United Kingdom

Countries where clinical trial is conducted

Ireland,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Survival without moderate or severe disability 24 months of age corrected for prematurity
Secondary Survival to discharge home Participants will be followed from trial entry until hospital discharge (typically at 36 corrected weeks' gestation), an expected average of 8 weeks.
Secondary Incidence of microbiologically-confirmed or clinically suspected late-onset invasive infection Participants will be followed from trial entry until hospital discharge (typically at 36 corrected weeks' gestation), an expected average of 8 weeks.
Secondary Incidence of necrotizing enterocolitis (Bell stage 2 or 3) Participants will be followed from trial entry until hospital discharge (typically at 36 corrected weeks' gestation), an expected average of 8 weeks.
Secondary Time taken to reach full milk feeds (tolerating 150 ml/kg/day for 3 consecutive days) Participants will be followed from trial entry until hospital discharge (typically at 36 corrected weeks' gestation), an expected average of 8 weeks.
Secondary Growth (weight and head circumference) at hospital discharge Measured by weight and head circumference z-scores Participants will be followed from trial entry until hospital discharge (typically at 36 corrected weeks' gestation), an expected average of 8 weeks.
Secondary Duration of parenteral feeding before hospital discharge Participants will be followed from trial entry until hospital discharge (typically at 36 corrected weeks' gestation), an expected average of 8 weeks.
Secondary Length of time in intensive care Participants will be followed from trial entry until hospital discharge (typically at 36 corrected weeks' gestation), an expected average of 8 weeks.
Secondary Length of hospital stay Participants will be followed from trial entry until hospital discharge (typically at 36 corrected weeks' gestation), an expected average of 8 weeks.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05048550 - Babies in Glasses; a Feasibility Study. N/A
Active, not recruiting NCT03655639 - Local Version of the Multi-center PREVENT Study Evaluating Cardio-respiratory Instability in Premature Infants
Enrolling by invitation NCT05542108 - Adding Motion to Contact: A New Model for Low-cost Family Centered Very-early Onset Intervention in Very Preterm-born Infants N/A
Completed NCT03680157 - Comparing Rater Reliability of Familiar Practitioners to Blinded Coders
Completed NCT03337659 - A Cluster Randomized Controlled Trial of FICare at 18 Months N/A
Completed NCT03649932 - Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing Phase 1
Completed NCT03251729 - Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix Phase 4
Not yet recruiting NCT05039918 - Neonatal Experience of Social Touch N/A
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Completed NCT02913495 - Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth Phase 4
Not yet recruiting NCT02880696 - Perception of Temporal Regularity in Tactile Stimulation: a Diffuse Correlation Spectroscopy Study in Preterm Neonates N/A
Completed NCT02952950 - Is it Possible to Prolong the Duration of Breastfeeding in Premature Infants? a Prospectivt Study N/A
Completed NCT02743572 - Iron-fortified Parenteral Nutrition in the Prevention and Treatment of Anemia in Premature Infants N/A
Completed NCT02661360 - Effects of Swaddling on Infants During Feeding N/A
Completed NCT02879799 - Family Integrated Care (FICare) in Level II NICUs N/A
Completed NCT01352234 - Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Phase 4
Completed NCT01163188 - Social Adjustment and Quality of Life After Very Preterm Birth N/A
Terminated NCT00675753 - Three Interacting Single Nucleotide Polymorphisms (SNPs) and the Risk of Preterm Birth in Black Families N/A
Terminated NCT00179972 - Evaluation of Pulse Oximetry Sensors in Neonates N/A

External Links